Prothena Corp. (PRTA)
8.79
0.00 (0.00%)
Upcoming Events
Latest Headlines
Form 4 PROTHENA CORP PUBLIC For: Jun 04 Filed by: SCULLY WILLIAM P
June 5, 2026 1:47 PM - SEC Filing
Form 4 PROTHENA CORP PUBLIC For: Jun 02 Filed by: SCULLY WILLIAM P
June 3, 2026 12:42 PM - SEC Filing
Form 4 PROTHENA CORP PUBLIC For: May 22 Filed by: SCULLY WILLIAM P
May 26, 2026 2:52 PM - SEC Filing
Form 4 PROTHENA CORP PUBLIC For: May 15 Filed by: WELCH DANIEL G
May 15, 2026 9:29 PM - SEC Filing
Form 4 PROTHENA CORP PUBLIC For: May 15 Filed by: Selkoe Dennis J.
May 15, 2026 9:29 PM - SEC Filing
Form 4 PROTHENA CORP PUBLIC For: May 15 Filed by: Ekman Lars
May 15, 2026 9:29 PM - SEC Filing
Form 4 PROTHENA CORP PUBLIC For: May 15 Filed by: Dunn William H. Jr.
May 15, 2026 9:28 PM - SEC Filing
Form 4 PROTHENA CORP PUBLIC For: May 15 Filed by: Cooke Shane
May 15, 2026 9:28 PM - SEC Filing
Form 4 PROTHENA CORP PUBLIC For: May 15 Filed by: COLLIER RICHARD T
May 15, 2026 9:28 PM - SEC Filing
Form 8-K PROTHENA CORP PUBLIC For: May 14
May 15, 2026 4:36 PM - SEC Filing
Form SCHEDULE 13G/A PROTHENA CORP PUBLIC Filed by: Rubric Capital Management LP
May 15, 2026 4:14 PM - SEC Filing
Form 3 PROTHENA CORP PUBLIC For: May 07 Filed by: SCULLY WILLIAM P
May 14, 2026 6:23 PM - SEC Filing
Form SCHEDULE 13G/A PROTHENA CORP PUBLIC Filed by: SCULLY WILLIAM P
May 11, 2026 3:26 PM - SEC Filing
Prothena Corp (PRTA) PT Raised to $20 at Citizens After Q1 Results
May 8, 2026 4:59 AM - StreetInsider
Prothena Corp. (PRTA) Tops Q1 EPS by 95c
May 7, 2026 4:53 PM - StreetInsider
Form 10-Q PROTHENA CORP PUBLIC For: Mar 31
May 7, 2026 4:23 PM - SEC Filing
Form 8-K PROTHENA CORP PUBLIC For: May 07
May 7, 2026 4:17 PM - SEC Filing
Prothena Reports First Quarter 2026 Financial Results and Business Highlights
May 7, 2026 4:05 PM - BizWire
Prothena to Report First Quarter 2026 Financial Results on May 7
April 30, 2026 4:05 PM - BizWire
Novo Nordisk gets FDA fast track status for ATTR heart disease drug
April 27, 2026 4:06 PM - StreetInsider
Prothena Announces Novo Nordisk Obtains Fast Track Designation from the U.S. FDA for Coramitug (PRX004) in ATTR Amyloidosis with Cardiomyopathy
April 27, 2026 4:05 PM - BizWire
Form 4 PROTHENA CORP PUBLIC For: Apr 10 Filed by: Kingston Anne Evans
April 10, 2026 7:22 PM - SEC Filing
Form 3 PROTHENA CORP PUBLIC For: Apr 10 Filed by: Kingston Anne Evans
April 10, 2026 7:22 PM - SEC Filing
Prothena promotes Kingston to strategy chief, Isaacs to general counsel
April 10, 2026 4:07 PM - StreetInsider
Prothena Announces Leadership Team Updates
April 10, 2026 4:05 PM - BizWire
Form ARS PROTHENA CORP PUBLIC For: Dec 31
March 27, 2026 4:20 PM - SEC Filing
Form DEFA14A PROTHENA CORP PUBLIC
March 27, 2026 4:14 PM - SEC Filing
Form DEF 14A PROTHENA CORP PUBLIC For: May 14
March 27, 2026 4:03 PM - SEC Filing
H.C. Wainwright Reiterates Buy Rating on Prothena Corp (PRTA)
March 24, 2026 6:39 AM - StreetInsider
Prothena Partners Present Data Supporting Next Generation Treatments for Parkinson’s and Alzheimer’s Disease at AD/PD™ 2026
March 21, 2026 4:05 PM - BizWire
Prothena (PRTA) Reiterated at Market Outperform by Citizens After Fireside Chat
March 13, 2026 6:30 AM - StreetInsider
Full Article List
